586 related articles for article (PubMed ID: 30851382)
1. Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.
Bhardwaj P; Au CC; Benito-Martin A; Ladumor H; Oshchepkova S; Moges R; Brown KA
J Steroid Biochem Mol Biol; 2019 May; 189():161-170. PubMed ID: 30851382
[TBL] [Abstract][Full Text] [Related]
2. Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer.
Wang X; Simpson ER; Brown KA
J Steroid Biochem Mol Biol; 2015 Sep; 153():35-44. PubMed ID: 26209254
[TBL] [Abstract][Full Text] [Related]
3. FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation.
Wellberg EA; Kabos P; Gillen AE; Jacobsen BM; Brechbuhl HM; Johnson SJ; Rudolph MC; Edgerton SM; Thor AD; Anderson SM; Elias A; Zhou XK; Iyengar NM; Morrow M; Falcone DJ; El-Hely O; Dannenberg AJ; Sartorius CA; MacLean PS
JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046001
[TBL] [Abstract][Full Text] [Related]
4. Inflammation, dysregulated metabolism and aromatase in obesity and breast cancer.
Zahid H; Simpson ER; Brown KA
Curr Opin Pharmacol; 2016 Dec; 31():90-96. PubMed ID: 27875786
[TBL] [Abstract][Full Text] [Related]
5. Obesity and breast cancer - Role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue.
Gérard C; Brown KA
Mol Cell Endocrinol; 2018 May; 466():15-30. PubMed ID: 28919302
[TBL] [Abstract][Full Text] [Related]
6. Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells.
Amanatullah DF; Tamaresis JS; Chu P; Bachmann MH; Hoang NM; Collyar D; Mayer AT; West RB; Maloney WJ; Contag CH; King BL
Breast Cancer Res; 2017 Nov; 19(1):121. PubMed ID: 29141657
[TBL] [Abstract][Full Text] [Related]
7. Aromatase, breast cancer and obesity: a complex interaction.
Bulun SE; Chen D; Moy I; Brooks DC; Zhao H
Trends Endocrinol Metab; 2012 Feb; 23(2):83-9. PubMed ID: 22169755
[TBL] [Abstract][Full Text] [Related]
8. Mammary adipose stromal cells derived from obese women reduce sensitivity to the aromatase inhibitor anastrazole in an organotypic breast model.
Morgan MM; Arendt LM; Alarid ET; Beebe DJ; Johnson BP
FASEB J; 2019 Jul; 33(7):8623-8633. PubMed ID: 31002529
[TBL] [Abstract][Full Text] [Related]
9. Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways.
Strong AL; Strong TA; Rhodes LV; Semon JA; Zhang X; Shi Z; Zhang S; Gimble JM; Burow ME; Bunnell BA
Breast Cancer Res; 2013; 15(5):R102. PubMed ID: 24176089
[TBL] [Abstract][Full Text] [Related]
10. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer.
Wang X; Docanto MM; Sasano H; ; Lo C; Simpson ER; Brown KA
Cancer Res; 2015 Feb; 75(4):645-55. PubMed ID: 25634217
[TBL] [Abstract][Full Text] [Related]
12. Heparanase Accelerates Obesity-Associated Breast Cancer Progression.
Hermano E; Goldberg R; Rubinstein AM; Sonnenblick A; Maly B; Nahmias D; Li JP; Bakker MAH; van der Vlag J; Vlodavsky I; Peretz T; Elkin M
Cancer Res; 2019 Oct; 79(20):5342-5354. PubMed ID: 31481501
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
14. Effect of obesity on breast cancer development.
Cleary MP; Grossmann ME; Ray A
Vet Pathol; 2010 Mar; 47(2):202-13. PubMed ID: 20124008
[TBL] [Abstract][Full Text] [Related]
15. FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer.
Castillo-Castrejon M; Sankofi BM; Murguia SJ; Udeme AA; Cen HH; Xia YH; Thomas NS; Berry WL; Jones KL; Richard VR; Zahedi RP; Borchers CH; Johnson JD; Wellberg EA
Breast Cancer Res; 2023 Aug; 25(1):99. PubMed ID: 37608351
[TBL] [Abstract][Full Text] [Related]
16. Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer link.
Zahid H; Subbaramaiah K; Iyengar NM; Zhou XK; Chen IC; Bhardwaj P; Gucalp A; Morrow M; Hudis CA; Dannenberg AJ; Brown KA
Int J Obes (Lond); 2018 Apr; 42(4):711-720. PubMed ID: 29104286
[TBL] [Abstract][Full Text] [Related]
17. Obesity-associated Breast Cancer: Analysis of risk factors.
Engin A
Adv Exp Med Biol; 2017; 960():571-606. PubMed ID: 28585217
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D mitigates the adverse effects of obesity on breast cancer in mice.
Swami S; Krishnan AV; Williams J; Aggarwal A; Albertelli MA; Horst RL; Feldman BJ; Feldman D
Endocr Relat Cancer; 2016 Apr; 23(4):251-64. PubMed ID: 26817629
[TBL] [Abstract][Full Text] [Related]
19. Estrogen metabolites and breast cancer.
Santen RJ; Yue W; Wang JP
Steroids; 2015 Jul; 99(Pt A):61-6. PubMed ID: 25168343
[TBL] [Abstract][Full Text] [Related]
20. The effect of adipocyte-macrophage crosstalk in obesity-related breast cancer.
Engin AB; Engin A; Gonul II
J Mol Endocrinol; 2019 Apr; 62(3):R201-R222. PubMed ID: 30620711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]